Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$337,700
+$231,365 QoQ
Shares Held
50,253
+264.8% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 133 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Derivatives in ARCT
reported options exposure · as of Mar 31, 2024CallValue
$1,013,100
CallShares
30,000
PutValue
$1,013,100
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. ARCT ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ARCT
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,700 | 50,253 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $106,335 | 13,774 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $210,167 | 34,285 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $456,494 | 35,088 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $171,430 | 10,102 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $762,541 | 32,854 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $718,300 | 29,499 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,013,100 | 30,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $1,013,100 | 30,000 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $277,306 | 8,795 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $358,900 | 14,047 | Shares | Defined | 2023-11-14 | |
| 2021-03-31 | $355,551 | 8,609 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $224,165 | 4,796 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||